European Council Brings SPC Manufacturing Waiver A Step Closer

A proposed SPC manufacturing waiver – which would allow generic and biosimilar manufacturing within Europe during the SPC period – has taken a step closer to being realized after the European Council approved a mandate for negotiations with the European Parliament. However, it remains uncertain whether key elements desired by the off-patent industry will fall into place.

EUFlag
The European Council Has Brought The SPC Manufacturing Waiver A Step Closer To Reality • Source: Shutterstock

A mandate for negotiations with the European Parliament on a draft Regulation outlining a waiver to allow manufacturing during the term of supplementary protection certificates (SPCs) has been approved by the European Council.

The move brings the long-awaited SPC manufacturing waiver a step closer to fruition, although it remains uncertain whether key elements...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Manufacturing

More from Business